Gastric cancer remains one of the leading causes of cancer-related death worldwide, and surgical resection with lymphadenectomy is the only potentially curative option. Lymphadenectomy—the systematic ...

First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): ...

Fluorescence-guided lymphadenectomy after neoadjuvant chemotherapy was linked to improved survival in gastric cancer. It was also significantly associated with more retrieved lymph nodes. The 3-year ...

Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO ...

An investigator reported 10-year follow-up data from a phase 3 trial of extended vs limited pelvic lymph node dissection during radical prostatectomy.